Literature DB >> 18451572

Bioinformatics based Ligand-Docking and in-silico screening.

Daisuke Takaya1, Mayuko Takeda-Shitaka, Genki Terashi, Kazuhiko Kanou, Mitsuo Iwadate, Hideaki Umeyama.   

Abstract

We report a novel method, ChooseLD (CHOOse biological information Semi-Empirically on the Ligand Docking), which uses simulated annealing (SA) based on bioinformatics for protein-ligand flexible docking. The fingerprint alignment score (FPAScore) value is used to determine the docking conformation of the ligand. This method includes the matching of chemical descriptors such as fingerprints (FPs) and the root mean square deviation (rmsd) calculation of the coordinates of atoms of the chemical descriptors. Here, the FPAScore optimization for the translation and rotation of a rigid body is performed using the Metropolis Monte Carlo method. Our ChooseLD method will find wide application in the field of biochemistry and medicine to improve the search for new drugs targeting various proteins implicated in diseases.

Mesh:

Substances:

Year:  2008        PMID: 18451572     DOI: 10.1248/cpb.56.742

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  9 in total

1.  Inhibition of bacterial undecaprenyl pyrophosphate synthase by small fungal molecules.

Authors:  Junji Inokoshi; Yuichiro Nakamura; Saori Komada; Katsuichiro Komatsu; Hideaki Umeyama; Hiroshi Tomoda
Journal:  J Antibiot (Tokyo)       Date:  2016-04-06       Impact factor: 2.649

2.  Principal component analysis-based unsupervised feature extraction applied to in silico drug discovery for posttraumatic stress disorder-mediated heart disease.

Authors:  Y-h Taguchi; Mitsuo Iwadate; Hideaki Umeyama
Journal:  BMC Bioinformatics       Date:  2015-04-30       Impact factor: 3.169

3.  Genes associated with genotype-specific DNA methylation in squamous cell carcinoma as candidate drug targets.

Authors:  Ryoichi Kinoshita; Mitsuo Iwadate; Hideaki Umeyama; Y-h Taguchi
Journal:  BMC Syst Biol       Date:  2014-01-24

4.  Bioinformatic screening of autoimmune disease genes and protein structure prediction with FAMS for drug discovery.

Authors:  Shigeharu Ishida; Hideaki Umeyama; Mitsuo Iwadate; Y-H Taguchi
Journal:  Protein Pept Lett       Date:  2014       Impact factor: 1.890

5.  TINAGL1 and B3GALNT1 are potential therapy target genes to suppress metastasis in non-small cell lung cancer.

Authors:  Hideaki Umeyama; Mitsuo Iwadate; Y-h Taguchi
Journal:  BMC Genomics       Date:  2014-12-08       Impact factor: 3.969

6.  An iterative compound screening contest method for identifying target protein inhibitors using the tyrosine-protein kinase Yes.

Authors:  Shuntaro Chiba; Takashi Ishida; Kazuyoshi Ikeda; Masahiro Mochizuki; Reiji Teramoto; Y-H Taguchi; Mitsuo Iwadate; Hideaki Umeyama; Chandrasekaran Ramakrishnan; A Mary Thangakani; D Velmurugan; M Michael Gromiha; Tatsuya Okuno; Koya Kato; Shintaro Minami; George Chikenji; Shogo D Suzuki; Keisuke Yanagisawa; Woong-Hee Shin; Daisuke Kihara; Kazuki Z Yamamoto; Yoshitaka Moriwaki; Nobuaki Yasuo; Ryunosuke Yoshino; Sergey Zozulya; Petro Borysko; Roman Stavniichuk; Teruki Honma; Takatsugu Hirokawa; Yutaka Akiyama; Masakazu Sekijima
Journal:  Sci Rep       Date:  2017-09-20       Impact factor: 4.379

7.  Chlamydomonas reinhardtii tubulin-gene disruptants for efficient isolation of strains bearing tubulin mutations.

Authors:  Takako Kato-Minoura; Yutaro Ogiwara; Takashi Yamano; Hideya Fukuzawa; Ritsu Kamiya
Journal:  PLoS One       Date:  2020-11-23       Impact factor: 3.240

8.  Identification of potential inhibitors based on compound proposal contest: Tyrosine-protein kinase Yes as a target.

Authors:  Shuntaro Chiba; Kazuyoshi Ikeda; Takashi Ishida; M Michael Gromiha; Y-H Taguchi; Mitsuo Iwadate; Hideaki Umeyama; Kun-Yi Hsin; Hiroaki Kitano; Kazuki Yamamoto; Nobuyoshi Sugaya; Koya Kato; Tatsuya Okuno; George Chikenji; Masahiro Mochizuki; Nobuaki Yasuo; Ryunosuke Yoshino; Keisuke Yanagisawa; Tomohiro Ban; Reiji Teramoto; Chandrasekaran Ramakrishnan; A Mary Thangakani; D Velmurugan; Philip Prathipati; Junichi Ito; Yuko Tsuchiya; Kenji Mizuguchi; Teruki Honma; Takatsugu Hirokawa; Yutaka Akiyama; Masakazu Sekijima
Journal:  Sci Rep       Date:  2015-11-26       Impact factor: 4.379

9.  A prospective compound screening contest identified broader inhibitors for Sirtuin 1.

Authors:  Shuntaro Chiba; Masahito Ohue; Anastasiia Gryniukova; Petro Borysko; Sergey Zozulya; Nobuaki Yasuo; Ryunosuke Yoshino; Kazuyoshi Ikeda; Woong-Hee Shin; Daisuke Kihara; Mitsuo Iwadate; Hideaki Umeyama; Takaaki Ichikawa; Reiji Teramoto; Kun-Yi Hsin; Vipul Gupta; Hiroaki Kitano; Mika Sakamoto; Akiko Higuchi; Nobuaki Miura; Kei Yura; Masahiro Mochizuki; Chandrasekaran Ramakrishnan; A Mary Thangakani; D Velmurugan; M Michael Gromiha; Itsuo Nakane; Nanako Uchida; Hayase Hakariya; Modong Tan; Hironori K Nakamura; Shogo D Suzuki; Tomoki Ito; Masahiro Kawatani; Kentaroh Kudoh; Sakurako Takashina; Kazuki Z Yamamoto; Yoshitaka Moriwaki; Keita Oda; Daisuke Kobayashi; Tatsuya Okuno; Shintaro Minami; George Chikenji; Philip Prathipati; Chioko Nagao; Attayeb Mohsen; Mari Ito; Kenji Mizuguchi; Teruki Honma; Takashi Ishida; Takatsugu Hirokawa; Yutaka Akiyama; Masakazu Sekijima
Journal:  Sci Rep       Date:  2019-12-20       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.